Effect of duloxetine and vitamin B12 on pain and numbness with chemotherapy-induced neuropathy
Phase 2
- Conditions
- malignant tumor
- Registration Number
- JPRN-UMIN000011554
- Lead Sponsor
- Higashi Sapporo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1) bad controlled liver, kidney, heart, lung , hypertension and infectious diseases 2) psychiatric diseases including depression 3) pregnancy or breast-feeding 4) intake MAO inhibitor (contraindication with duloxetine) 5) the cases whom the doctor decide not to be the indication
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method numbness and pain (VAS)
- Secondary Outcome Measures
Name Time Method neurological symptoms (CTCAE)